Arena Pharmaceuticals Inc (NASDAQ:ARNA)
| 45.80 Delayed Data As of Jan 22 |  +0.38 / +0.84%Today’s Change | 42.25 Today|||52-Week Range 64.48 | +0.84% Year-to-Date |
Latest ARNA News | Press Releases
No recent news for Arena Pharmaceuticals Inc.
Today’s Trading
| Previous close | 45.42 |
| Today’s open | 45.84 |
| Day’s range | 45.55 - 46.17 |
| Volume | 392,721 |
| Average volume (3 months) | 385,301 |
| Market cap | $2.3B |
Data as of 4:00pm ET, 01/22/2020
Growth & Valuation
| Earnings growth (last year) | +76.88% |
| Earnings growth (this year) | +1,388.69% |
| Earnings growth (next 5 years) | -45.30% |
| Revenue growth (last year) | -15.78% |
| P/E ratio | 4.2 |
| Price/Sales | 101.96 |
| Price/Book | 3.76 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RARXRa Pharmaceuticals I... | +0.01 | +0.02% |
| ---- | ||
| ZGNXZogenix Inc | +0.30 | +0.55% |
| FOLDAmicus Therapeutics ... | -0.10 | -0.97% |
Data as of 4:00pm ET, 01/22/2020
Financials
| Next reporting date | March 12, 2020 |
| EPS forecast (this quarter) | -$1.54 |
| Annual revenue (last year) | $18.0M |
| Annual profit (last year) | -$30.1M |
| Net profit margin | -158.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
